Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Prospective Single-arm Study of Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer

NCT07420517 is registered in ClinicalTrials.gov with Paul Toren as lead sponsor.

NCT NCT07420517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07420517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Prospective Single-arm Study of Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Lead sponsor
Paul Toren
Phase
Phase 2
Overall status
Recruiting
Start date
March 25, 2026
Completion date
April 2, 2032
Enrollment
95 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer